News
With a backdrop of mounting industry disruption and transition, Pharm Exec’s latest listing of the top global biopharma sales ...
Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...
56m
Zacks.com on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results